- Home
- ACIU vs AIRJ Comparison
ACIU vs AIRJ Comparison
Compare ACIU & AIRJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- AIRJ
- Stock Information
- Founded
- ACIU 2003
- AIRJ 2018
- Country
- ACIU Switzerland
- AIRJ United States
- Employees
- ACIU N/A
- AIRJ N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- AIRJ
- Sector
- ACIU Health Care
- AIRJ
- Exchange
- ACIU Nasdaq
- AIRJ NYSE
- Market Cap
- ACIU 189.1M
- AIRJ 256.6M
- IPO Year
- ACIU 2016
- AIRJ N/A
- Fundamental
- Price
- ACIU $2.03
- AIRJ $4.44
- Analyst Decision
- ACIU Strong Buy
- AIRJ Strong Buy
- Analyst Count
- ACIU 1
- AIRJ 1
- Target Price
- ACIU $12.00
- AIRJ $12.00
- AVG Volume (30 Days)
- ACIU 120.2K
- AIRJ 296.8K
- Earning Date
- ACIU 08-05-2025
- AIRJ 08-22-2025
- Dividend Yield
- ACIU N/A
- AIRJ N/A
- EPS Growth
- ACIU N/A
- AIRJ N/A
- EPS
- ACIU N/A
- AIRJ 0.86
- Revenue
- ACIU $32,014,254.00
- AIRJ N/A
- Revenue This Year
- ACIU N/A
- AIRJ N/A
- Revenue Next Year
- ACIU $533.21
- AIRJ N/A
- P/E Ratio
- ACIU N/A
- AIRJ $5.23
- Revenue Growth
- ACIU 91.20
- AIRJ N/A
- 52 Week Low
- ACIU $1.43
- AIRJ $3.74
- 52 Week High
- ACIU $4.26
- AIRJ $11.75
- Technical
- Relative Strength Index (RSI)
- ACIU 56.32
- AIRJ 53.05
- Support Level
- ACIU $2.03
- AIRJ $4.56
- Resistance Level
- ACIU $2.15
- AIRJ $4.91
- Average True Range (ATR)
- ACIU 0.14
- AIRJ 0.39
- MACD
- ACIU -0.00
- AIRJ -0.01
- Stochastic Oscillator
- ACIU 79.28
- AIRJ 32.26
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About AIRJ MONTANA TECHNOLOGIES CORP
AirJoule Technologies Corp is the developer of AirJoule, an atmospheric water harvesting technology that provides efficient and sustainable air dehumidification and pure water from air. AirJoule can also enable transformative HVAC products to help customers save money on their energy bills while reducing environmental impact.